Melanotan II: regulatory warnings and risk context
FDA consumer warnings, unapproved status, and why tanning or libido claims are not benign.
Educational information only — not medical advice. This page does not diagnose conditions, recommend treatment, or replace care from a qualified clinician. The Peptide Center uses an evidence-first editorial process: regulatory sources, trial registries, and peer-reviewed research take priority; uncertainty is stated rather than filled with promises.
Melanotan II is not an FDA-approved drug. FDA has issued consumer warnings that it is unapproved and potentially dangerous, citing serious side effects including cardiovascular and gastrointestinal events. Products sold online as "Melanotan II" or "MT-2" have not undergone FDA review for safety, effectiveness, or quality.
References
Related resources
Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.
ARA-290
An overview of erythropoietin-derived peptide research without turning orphan-drug development into a wellness claim.
Open resourcePeptide briefBPC-157
A conservative review of what laboratory findings can and cannot tell us about BPC-157.
Open resourcePeptide briefCardiogen
Why the same acronym can refer to different molecules, salts, fragments, or blends.
Open resourcePeptide briefCartalax
Why a compelling cell or animal result is the beginning of a question, not the end of it.
Open resourcePeptide briefCurcumin
Why the same acronym can refer to different molecules, salts, fragments, or blends.
Open resourcePeptide briefGHK-Cu
How to read the GHK-Cu literature without turning mechanisms or models into clinical promises.
Open resourceArticleKPV: anti-inflammatory tripeptide research
How to read KPV gut-skin and inflammation literature without overstating preclinical findings.
Open resourceArticleARA-290 (cibinetide): neuropathy and repair research
An overview of erythropoietin-derived peptide research without turning orphan-drug development into a wellness claim.
Open resource